ATE15445T1 - System zur produktion von cystein. - Google Patents

System zur produktion von cystein.

Info

Publication number
ATE15445T1
ATE15445T1 AT82100980T AT82100980T ATE15445T1 AT E15445 T1 ATE15445 T1 AT E15445T1 AT 82100980 T AT82100980 T AT 82100980T AT 82100980 T AT82100980 T AT 82100980T AT E15445 T1 ATE15445 T1 AT E15445T1
Authority
AT
Austria
Prior art keywords
cysteine
oxothiazolidine
carboxylate
production
prolinase
Prior art date
Application number
AT82100980T
Other languages
English (en)
Inventor
Alton Meister
Joanne M Williamson
Original Assignee
Cornell Res Foundation Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cornell Res Foundation Inc filed Critical Cornell Res Foundation Inc
Application granted granted Critical
Publication of ATE15445T1 publication Critical patent/ATE15445T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P13/00—Preparation of nitrogen-containing organic compounds
    • C12P13/04—Alpha- or beta- amino acids
    • C12P13/12—Methionine; Cysteine; Cystine

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicinal Preparation (AREA)
  • Feed For Specific Animals (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Threshing Machine Elements (AREA)
  • Cosmetics (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
AT82100980T 1981-02-11 1982-02-10 System zur produktion von cystein. ATE15445T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/233,564 US4335210A (en) 1981-02-11 1981-02-11 Method of producing L-cysteine
EP82100980A EP0057942B1 (de) 1981-02-11 1982-02-10 System zur Produktion von Cystein

Publications (1)

Publication Number Publication Date
ATE15445T1 true ATE15445T1 (de) 1985-09-15

Family

ID=22877749

Family Applications (1)

Application Number Title Priority Date Filing Date
AT82100980T ATE15445T1 (de) 1981-02-11 1982-02-10 System zur produktion von cystein.

Country Status (8)

Country Link
US (1) US4335210A (de)
EP (1) EP0057942B1 (de)
JP (1) JPS57188513A (de)
AT (1) ATE15445T1 (de)
CA (1) CA1167766A (de)
DE (1) DE3266087D1 (de)
DK (1) DK48882A (de)
NO (1) NO820399L (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4647571A (en) * 1981-02-11 1987-03-03 Cornell Research Foundation Cysteine delivery composition
CH654302A5 (de) * 1983-05-04 1986-02-14 Sandoz Ag Acylaminophenolderivate, ihre herstellung und arzneimittel, welche sie enthalten.
US4868114A (en) * 1987-08-05 1989-09-19 Regents Of The University Of Minnesota Method for elevating glutathione levels
DE68921436T2 (de) * 1988-12-09 1995-08-10 Allergan Inc Verwendung von 2-substituierten Thiazolidin-4-carbonsäuren zur Behandlung von Katarakt.
CA1339256C (en) * 1989-01-26 1997-08-12 Wulf Droge Treatment of diseases associated with hiv-infections
US5580577A (en) * 1990-01-11 1996-12-03 Herzenberg; Leonard A. Method of treating the symptoms of human rhinovirus infection
JP2769243B2 (ja) * 1990-02-19 1998-06-25 ノボ ノルディスク アクティーゼルスカブ 溶液、特に発酵溶液から精製ｅｐｉ蛋白質の回収方法
DK0494405T3 (da) * 1991-01-10 1996-11-18 Transcend Therapeutics Inc Anvendelse af thiazolidin-4-carboxylatderivater til behandling af lungesygdomme
US5747459A (en) * 1991-02-04 1998-05-05 Nestec, Ltd. Method for insuring adequate intracellular glutathione in tissue
EP0535390B1 (de) * 1991-09-30 1996-05-15 Transcend Therapeutics, Inc. Verwendung von L-2-Oxothiazolidine-4-Carboxylate zur Herstellung eines Arzneimittels zur Behandlung von latenten HIV-Infektionen
AU661379B2 (en) * 1992-04-23 1995-07-20 Transcend Therapeutics, Inc Method of reducing or preventing toxicity associated with antiretroviral therapy
US5430045A (en) * 1992-04-23 1995-07-04 Free Radical Sciences, Inc. Method of reducing or preventing bone marrow hypoplasia
US5208249A (en) * 1992-08-20 1993-05-04 Clintec Nutrition Co. Method for stimulating intracellular synthesis of glutathione using esters of L-2-oxothiazolidine-4-carboxylate
US5589464A (en) * 1992-09-01 1996-12-31 Allergan Use of 2-substituted-thiazolidine-4-carboxylic acids for treatment of cataract
AU5040493A (en) 1992-11-30 1994-06-09 Transcend Therapeutics, Inc Method for treating systemic inflammatory response syndrome
US5447712A (en) * 1993-12-09 1995-09-05 Free Radical Sciences Method of reducing cyclophosphamide induced hemorrhagic cystitis
FR2742658B1 (fr) * 1995-12-22 1998-01-30 Oreal Utilisation de la procysteine comme agent depigmentant
US5780489A (en) * 1996-08-21 1998-07-14 Brooks; Benjamin Rix Method for treating amyotrophic lateral sclerosis
DE19711053C2 (de) * 1997-03-03 1999-09-02 Rommelspacher Kombinationspräparat aus 2-Methyl-thiazolidin-2,4-dicarbonsäure und Paracetamol
WO2001012166A2 (en) 1999-08-17 2001-02-22 University Of Saskatchewan Technologies Inc. Improved treatment for acute physical insult to the central nervous system
EP1372641A4 (de) * 2001-03-05 2004-08-25 Stephen P Ernest Enterale formulierung
US20060105972A1 (en) * 2004-11-17 2006-05-18 Nagasawa Herbert T Method to enhance delivery of glutathione and ATP levels in cells
TW201201712A (en) * 2010-01-28 2012-01-16 Max International Llc Compositions comprising sugar-cysteine products
TW201202209A (en) * 2010-01-28 2012-01-16 Max International Llc Methods of preparing thiazolidines
US10239847B1 (en) 2016-03-03 2019-03-26 Cellactin Method for 2-oxothiazolidine-4-carboxylic acid for cellular glutathione

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2034536A1 (en) * 1969-02-11 1970-12-11 Academia Republ Roman A Thiazolidinecarboxylic acid-4derivs
US3974031A (en) * 1974-05-09 1976-08-10 Mitsubishi Chemical Industries Ltd. Process for producing L-cysteine or its derivatives
US4006057A (en) * 1974-11-06 1977-02-01 Ajinomoto Co., Inc. Method of producing L-cysteine and L-cystine
JPS5272883A (en) * 1975-12-12 1977-06-17 Ajinomoto Co Inc Preparation of sulfur-containing amino acid
US4384001A (en) * 1978-12-21 1983-05-17 Gosalvez Mario Treatment of tumors with thiazolidine-4-carboxylic acid

Also Published As

Publication number Publication date
NO820399L (no) 1982-08-12
US4335210A (en) 1982-06-15
DK48882A (da) 1982-08-12
JPS57188513A (en) 1982-11-19
EP0057942A2 (de) 1982-08-18
CA1167766A (en) 1984-05-22
DE3266087D1 (en) 1985-10-17
EP0057942B1 (de) 1985-09-11
EP0057942A3 (en) 1982-10-27

Similar Documents

Publication Publication Date Title
ATE15445T1 (de) System zur produktion von cystein.
FI101720B1 (fi) Synteettisen DNA:n konstruointi ja sen käyttö suurten polypeptidien synteesissä
EP1005874A4 (de) Hyaluronsäure-gel, verfahren zur dessen herstellung und hyaluronsäure-gel enthaltendes medizinisches material
DK0474790T3 (da) Medier til cellevækst og fremgangsmåde til fremstilling deraf
DK0471754T3 (da) Produktion af vaskulær endotelcelle vækstfaktor, samt DNA kodende for denne
ES2052829T3 (es) Aminoetiltetralinas substituidas asi como sus analogos heterociclicos.
DE3888642D1 (de) Rollflasche zur Züchtung von Zellengewebekulturen.
ATA86885A (de) Verfahren zur herstellung lagerstabiler, schnellzerfallender pharmazeutischer wirkstoff-presslinge
ES2181689T3 (es) Variantes del factor de crecimiento de hepatocitos.
DK0454898T3 (da) Glycosaminoglycan-modificeret protein, fremgangsmåde til fremstilling af proteinet, farmaceutiske præparater indeholdende proteinet samt anvendelse af proteinet
ES444558A1 (es) Procedimiento para la produccion de una preparacion estable de insulina.
DE69132902D1 (de) Methoden zur identifizierung heterofunktionaler fusionsproteine
EP0237966A3 (de) Menschlicher basischer Fibroblast-Wachstumsfaktor
SE8804570D0 (sv) New ciclosporin crystal form process for its produktion pharmaceutical compositions containing it and its use
ES449707A1 (es) Un procedimiento para el acondicionamiento alcalino o neutrodel colageno para extraccion de gelatina.
DE3864512D1 (de) Verfahren zur herstellung von kandis mit gepressten gaszellen.
DE69034128D1 (de) Saccharose-Phosphat-Synthase (SPS), ihr Verfahren zur Herstellung, ihr cDNA und Verwendung von cDNA zur Veränderung der SPS-Expression in Pflanzenzellen
FI880151A0 (fi) -glutamyylitranspeptidaasin käyttö glutaryyli-7-amino- tai -ketoadipinyylikefalosporaanihapon entsymaattiseen hydrolysointiin
ES2052513T3 (es) Nuevos polipeptidos, su fabricacion y empleo.
DE3783145D1 (de) Rekombinantes dns-plasmid zur herstellung von xanthangummi.
DE58903876D1 (de) Riboflavin-4'5'-cyclo-phosphorsaeureesterchlorid, dessen herstellung und verwendung zur herstellung von riboflavin-5'-phosphat (5'-fmn) bzw. dessen natriumsalz.
DE50013563D1 (de) Verwendung von pankreatischer Procarboxypeptidase B zur Herstellung von Insulin
ES2059340T3 (es) Un metodo de preparacion de proteinas.
ES486851A1 (es) Un procedimiento de preparacion de acido 3a,7b-dihidroxico- lanico
IE780205L (en) Insulin-secretion promoting protein.

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee